Vertaling van "were added " (Nederlands → Frans) :

53 percent of AD caregivers surveyed who said they were not very involved (somewhat or not at all involved) in these interactions were dissatisfied with their loved one’s treatment, as compared with 31 percent who said they were engaged
· 53 percent of AD caregivers surveyed who sa id they were not very involved (somewhat or not at all involved) in these interactions were dissatisfied with their loved one’s treatment, as compared with 31 percent who said they were engaged

In fact, 67 percent of AD caregivers surveyed said changes in cognitive symptoms were among their main concerns.
In fact, 67 percent of AD caregivers surveyed sa id changes in cognitive symptoms were among their main concerns .

The three greatest caregiver concerns about the progression of their loved one’s AD were memory loss (41 percent), personal safety (33 percent) and confusion (27 percent)
· The three greatest caregiver concerns about the progression of their loved one’s AD were memory loss (41 percent), personal safety (33 percent) and confusion (27 percent)

Positive data from the ALOFT (heart failure) and AVOID (kidney disease) clinical studies, which are part of the ASPIRE HIGHER cardio-renal outcomes program, were added to European product information.
Des données favorables provenant des études ALOFT (insuffisance cardiaque) et AVOID (maladies rénales), qui font partie du programme ASPIRE HIGHER qui explore les bénéfices du médicament en termes de protection cardiaque et rénale, ont été ajoutées à l’information du produit en Europe.

These roadshows were evaluated by the attendees and received a particularly high score; the roadshows also received a lot of coverage in the trade press and have led to a list of questions and answers (FAQ) which is discussed and added to at each presentation.
These roadshows were evaluated by the attendees and received a particularly high score; the roadshows also received a lot of coverage in the trade press and have led to a list of questions and answers (FAQ) which is discussed and added to at each presentation.